CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities
Net income	$ 28,406	$ 22,383
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,604	2,370
Deferred income taxes	0	105
Stock-based compensation, net of amounts capitalized	14,001	9,506
Non-cash lease expense	537	401
Amortization of premium (accretion of discount) on marketable securities, net	(299)	1,455
Loss on sale of marketable securities	273	37
Amortization of deferred contract costs	2,667	2,767
Other	(152)	(30)
Changes in operating assets and liabilities, net of effect of acquisition:
Accounts receivable	14,032	5,533
Prepaid expenses and other assets	2,589	1,246
Deferred contract costs	(1,210)	(866)
Accounts payable, accrued expenses and other liabilities	677	(6,109)
Deferred revenue	(6,922)	6,152
Operating lease liabilities	(3)	(198)
Net cash provided by operating activities	57,200	44,752
Cash flows from investing activities
Cash paid for acquisition	0	(53,500)
Purchases of property and equipment	(70)	(710)
Internal-use software development costs	(1,494)	(1,415)
Purchases of marketable securities	(35,284)	(8,870)
Maturities of marketable securities	116,649	8,271
Sales of marketable securities	37,525	14,724
Net cash provided by (used in) investing activities	117,326	(41,500)
Cash flows from financing activities
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants	3,285	3,014
Taxes paid related to net share settlement of equity awards	(1,964)	(109)
Repurchase of common stock	(21,755)	(8,874)
Payment of contingent consideration related to a business combination	(5,390)	0
Net cash used in financing activities	(25,824)	(5,969)
Net increase (decrease) in cash and cash equivalents	148,702	(2,717)
Cash and cash equivalents, beginning of period	158,027	112,809
Cash and cash equivalents, end of period	306,729	110,092
Supplemental disclosures of cash flow information
Cash paid for taxes	0	0
Non-cash financing and investing activities
Fair value of contingent earn-out consideration included in purchase consideration	0	21,134
Operating lease right-of-use assets obtained in exchange for operating lease liabilities	$ 0	$ 10,877

Increase (Decrease) In Capitalized Contract Cost

No definition available.

Name:	docs_IncreaseDecreaseInCapitalizedContractCost
Namespace Prefix:	docs_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.